At the IGTP TODAY

News

CEEISCAT advances Pan-Téstate to strengthen online screening for HIV and viral hepatitis among GBMSM and trans women in Spain

CEEISCAT, a research group at IGTP, is developing Pan-Téstate, an online self-sampling program aimed at improving early screening for HIV and viral hepatitis among GBMSM and trans women in Spain. Using dried blood spot samples collected at home, the initiative seeks to reduce barriers to testing and improve access to early diagnosis and prevention.

Escoles Sentinella 2024–2025 Report published: five years of participatory research consolidating an innovative model between public health and education

The Escoles Sentinella project, coordinated by the CEEISCAT Group at IGTP, presented the main results of its fifth and final academic year. This initiative has shown that the network is viable and generates relevant scientific evidence on school health through collaboration between schools, researchers and public institutions.

- Conferences, Projects, Research

IGTP coordinates European project TB-SPECTRUM to advance understanding of the tuberculosis disease spectrum

IGTP has launched the European project TB-SPECTRUM, funded under the Horizon Europe programme through the MSCA Staff Exchanges scheme and coordinated by IGTP. A kick-off meeting held online brought together researchers, clinicians, and representatives from academic and non-academic institutions across Europe, Africa, and the United States, alongside members of the project's External Scientific and Ethics Advisory Boards.

The Fundació Catalunya La Pedrera awards 33 Talents Grants to retain medical and research talent in Catalonia

The Talents Grants for the 2024 and 2025 editions have been granted by the Fundació Catalunya La Pedrera, supporting healthcare professionals in developing research projects that will lead to their doctoral theses. This initiative, originally created through a collaboration with the Research Institute and Hospital Germans Trias i Pujol, now also includes Hospital Clínic Barcelona, the Vall d'Hebron Institute of Oncology and Hospital de Bellvitge.